Get startedLog in
    Picture of Theriva Biologics logo

    TOVX — Theriva Biologics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer

    Picture of Theriva Biologics logoTheriva Biologics
    23/05/2024 13:48
    May 23 (Reuters) - Theriva Biologics Inc  TOVX.A :
    * THERIVA™ BIOLOGICS ANNOUNCES FAST TRACK DESIGNATION
GRANTED BY
THE U.S. FDA FOR VCN-01 FOR THE TREATMENT OF METASTATIC
PANCREATIC CANCER

Source text for Eikon:  ID:nGNX4h00z9 
Further company coverage:  TOVX.A 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Theriva Biologics

    See all news